Complement C4 phenotypes in patients with end-stage renal disease

Area of Science:

• Immunogenetics
• Nephrology
• Complement System Biology

Background:

• The complement system, particularly complement C4 (C4), plays a crucial role in immune responses.
• Alterations in C4 phenotypes have been implicated in various diseases, including renal failure.
• Uremia, a syndrome resulting from chronic kidney disease, may influence protein structure and function.

Purpose of the Study:

• To investigate complement C4 phenotypes in patients with end-stage renal failure.
• To compare C4 allotype frequencies between patients and healthy controls.
• To identify and characterize potential acquired C4 variants in uremic patients.

Main Methods:

• Agarose gel electrophoresis was employed to determine C4 phenotypes.
• 130 patients with end-stage renal failure and 140 healthy controls were analyzed.
• Statistical analysis was used to compare allele frequencies and identify significant differences.

Main Results:

• No significant differences in C4 allotype frequencies were observed between patients and controls.
• Increased frequencies of null alleles for C4A and C4B were noted in the patient group, though not statistically significant.
• Significantly higher frequencies of C4AQ0 and two null alleles were found in type 1 diabetic patients.
• Previously undescribed acquired uremic variants of C4A3, C4B1, C4B2, and C4B3 were detected in uremic patients.
• These uremic variants appeared early in chronic renal failure and disappeared post-transplantation.

Conclusions:

• Acquired uremic C4 variants represent a novel phenotype associated with chronic renal failure.
• The exact mechanism causing these uremic variants remains unclear but may involve carbamylation.
• Further research is needed to elucidate the functional implications of these acquired C4 variants in uremia.